The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Molecular neurobiology

Volumn 47, Issue 2, 2013, Pages 495-508

  Wakabayashi, Koichi ^a   Tanji, Kunikazu ^b   Odagiri, Saori ^b   Miki, Yasuo ^b   Mori, Fumiaki ^b   Takahashi, Hitoshi ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL; DIFFUSE LEWY BODY DISEASE; HUMAN; LEWY BODY; METABOLISM; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; TOXICITY;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS; LEWY BODIES; LEWY BODY DISEASE; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 84879122389     PISSN: None     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8280-y     Document Type: Review

References (226)

1. 1. A Iwai E Masliah M Yoshimoto 1995 The precursor protein of non-Aβ component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system Neuron 14 467 475 7857654 1:CAS:528:DyaK2MXjvFejsLY%3D 10.1016/0896-6273(95)90302-X Iwai A, Masliah E, Yoshimoto M et al (1995) The precursor protein of non-Aβ component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467–475
2. 2. MH Polymeropoulos C Lavedan E Leroy 1997 Mutation in the α-synuclein gene identified in families with Parkinson’s disease Science 276 2045 2047 9197268 1:CAS:528:DyaK2sXkt1altr4%3D 10.1126/science.276.5321.2045 Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047
3. 3. R Krüger W Kuhn T Muller 1998 Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease Nat Genet 18 106 108 9462735 10.1038/ng0298-106 Krüger R, Kuhn W, Muller T et al (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat Genet 18:106–108
4. 4. JJ Zarranz J Alegre JC Gomez-Esteban 2004 The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 164 173 14755719 1:CAS:528:DC%2BD2cXhs1Sgtb0%3D 10.1002/ana.10795 Zarranz JJ, Alegre J, Gomez-Esteban JC et al (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164–173
5. 5. AB Singleton M Farrer J Johnson 2003 α-Synuclein locus triplication causes Parkinson’s disease Science 302 841 14593171 1:CAS:528:DC%2BD3sXoslehsbc%3D 10.1126/science.1090278 Singleton AB, Farrer M, Johnson J et al (2003) α-Synuclein locus triplication causes Parkinson’s disease. Science 302:841
6. 6. MG Spillantini ML Schmidt VM-Y Lee JQ Trojanowski R Jakes M Goedert 1997 α-Synuclein in Lewy bodies Nature 388 839 840 9278044 1:CAS:528:DyaK2sXlslWru7o%3D 10.1038/42166 Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840
7. 7. M Baba S Nakajo PH Tu 1998 Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies Am J Pathol 152 879 884 9546347 1:CAS:528:DyaK1cXivVKgsbc%3D Baba M, Nakajo S, Tu PH et al (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 152:879–884
8. 8. K Seidel L Schols S Nuber 2010 First appraisal of brain pathology owing to A30P mutant alpha-synuclein Ann Neurol 67 684 689 20437567 1:CAS:528:DC%2BC3cXmvF2lsrc%3D 10.1002/ana.22078 Seidel K, Schols L, Nuber S et al (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684–689
9. 9. S Arawaka Y Saito S Murayama H Mori 1998 Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein Neurology 51 887 889 9748051 1:CAS:528:DyaK1cXmtlOks74%3D 10.1212/WNL.51.3.887 Arawaka S, Saito Y, Murayama S, Mori H (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein. Neurology 51:887–889
10. 10. K Wakabayashi M Yoshimot T Fukushima 1999 Widespread occurrence of α-synuclein/NACP-immunoreactive neuronal inclusions in juvenile-and adult-onset Hallervorden–Spatz disease with Lewy bodies Neuropathol Appl Neurobiol 125 363 368 10.1046/j.1365-2990.1999.00193.x Wakabayashi K, Yoshimot M, Fukushima T et al (1999) Widespread occurrence of α-synuclein/NACP-immunoreactive neuronal inclusions in juvenile-and adult-onset Hallervorden–Spatz disease with Lewy bodies. Neuropathol Appl Neurobiol 125:363–368
11. 11. C Paisan-Ruiz A Li SA Schneider 2012 Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations Neurobiol Aging 33 814 823 20619503 1:CAS:528:DC%2BC38XitlOksb8%3D 10.1016/j.neurobiolaging.2010.05.009 Paisan-Ruiz C, Li A, Schneider SA et al (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33:814–823
12. 12. K Wong E Sidransky A Verma 2004 Neuropathology provides clue to the pathophysiology of Gaucher disease Mol Genet Metab 82 192 207 15234332 1:CAS:528:DC%2BD2cXlsVSgu74%3D 10.1016/j.ymgme.2004.04.011 Wong K, Sidransky E, Verma A et al (2004) Neuropathology provides clue to the pathophysiology of Gaucher disease. Mol Genet Metab 82:192–207
13. 13. R Hamilton 2000 Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry Brain Pathol 10 378 384 10885656 1:STN:280:DC%2BD3cvotFWktw%3D%3D 10.1111/j.1750-3639.2000.tb00269.x Hamilton R (2000) Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol 10:378–384
14. 14. Y Saito K Suzuki CM Hulette S Murayama 2004 Aberrant phosphorylation of alpha-synuclein in human Niemann–Pick type C1 disease J Neuroapthol Exp Neurol 63 323 328 1:CAS:528:DC%2BD2cXjs1Wgs70%3D Saito Y, Suzuki K, Hulette CM, Murayama S (2004) Aberrant phosphorylation of alpha-synuclein in human Niemann–Pick type C1 disease. J Neuroapthol Exp Neurol 63:323–328
15. 15. K Suzuki E Iseki T Togo 2007 Neuronal and glial accumulation of α-and β-synucleins in human lipidoses Acta Neuropathol 114 481 489 17653558 1:CAS:528:DC%2BD2sXhtFWru7jL 10.1007/s00401-007-0264-z Suzuki K, Iseki E, Togo T et al (2007) Neuronal and glial accumulation of α-and β-synucleins in human lipidoses. Acta Neuropathol 114:481–489
16. 16. SE Winder-Rhodes P Garcia-Reitbock M Ban 2012 Genetic and pathological links between Parkinson’s disease and the lysosomal disorder Sanfilippo syndrome Mov Disord 27 312 315 22102531 1:CAS:528:DC%2BC38Xhs1Glur%2FK 10.1002/mds.24029 Winder-Rhodes SE, Garcia-Reitbock P, Ban M et al (2012) Genetic and pathological links between Parkinson’s disease and the lysosomal disorder Sanfilippo syndrome. Mov Disord 27:312–315
17. 17. K Wakabayashi M Yoshimoto S Tsuji H Takahashi 1998 α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci Lett 249 180 182 9682846 1:CAS:528:DyaK1cXjvVWisLg%3D 10.1016/S0304-3940(98)00407-8 Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180–182
18. 18. P-H Tu JE Galvin M Baba 1998 Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein Ann Neurol 44 415 422 9749615 1:CAS:528:DyaK1cXmtFKls7w%3D 10.1002/ana.410440324 Tu P-H, Galvin JE, Baba M et al (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 44:415–422
19. 19. K Arima K Uéda N Sunohara 1998 NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy Acta Neuropathol 96 439 444 9829806 1:CAS:528:DyaK1cXmtFegtLc%3D 10.1007/s004010050917 Arima K, Uéda K, Sunohara N et al (1998) NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol 96:439–444
20. 20. FH Lewy 1912 Paralysis agitans. I. Pathologische Anatomie M Lewandowsky Hundbuch der Neurologie III Springer Berlin 920 933 Lewy FH (1912) Paralysis agitans. I. Pathologische Anatomie. In: Lewandowsky M (ed) Hundbuch der Neurologie III. Springer, Berlin, pp 920–933
21. 21. Tretiakoff MC (1919) Contribution a l’étude de l’anatomie pathologique de Locus Niger de Soemmerling. Université de Paris.
22. 22. K Wakabayashi H Takahashi K Obata F Ikuta 1992 Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson’s disease Neurosci Lett 138 237 240 1608535 1:CAS:528:DyaK38XktVGnsb8%3D 10.1016/0304-3940(92)90923-U Wakabayashi K, Takahashi H, Obata K, Ikuta F (1992) Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson’s disease. Neurosci Lett 138:237–240
23. 23. PE Duffy VM Tennyson 1965 Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson’s disease J Neuropathol Exp Neurol 24 398 414 10.1097/00005072-196507000-00003 Duffy PE, Tennyson VM (1965) Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson’s disease. J Neuropathol Exp Neurol 24:398–414
24. 24. K Kosaka 1978 Lewy bodies in cerebral cortex. Report of three cases Acta Neuropathol 42 127 134 654884 1:STN:280:DyaE1c7otlOnsQ%3D%3D 10.1007/BF00690978 Kosaka K (1978) Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol 42:127–134
25. 25. J Lowe A Blanchard K Morrell 1988 Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease J Pathol 155 9 15 2837558 1:STN:280:DyaL1c3ksV2gsA%3D%3D 10.1002/path.1711550105 Lowe J, Blanchard A, Morrell K et al (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 155:9–15
26. 26. S Kuzuhara H Mori N Izumiyama M Yoshimura Y Ihara 1988 Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study Acta Neuropathol 75 345 353 3364159 1:CAS:528:DyaL1cXhs1GlsL8%3D 10.1007/BF00687787 Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 75:345–353
27. 27. H Fujiwara M Hasegawa N Dohmae 2002 α-Synuclein is phosphorylated in synucleinopathy lesions Nature Cell Biol 4 160 164 11813001 1:CAS:528:DC%2BD38Xms1ahtLo%3D 10.1038/ncb841 Fujiwara H, Hasegawa M, Dohmae N et al (2002) α-Synuclein is phosphorylated in synucleinopathy lesions. Nature Cell Biol 4:160–164
28. 28. Y Saito A Kawashima NN Ruberu 2003 Accumulation of phosphorylated α-synuclein in aging human brain J Neuropathol Exp Neurol 62 644 654 12834109 1:CAS:528:DC%2BD3sXlt1yqu78%3D Saito Y, Kawashima A, Ruberu NN et al (2003) Accumulation of phosphorylated α-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644–654
29. 29. DW Dickson D Ruan H Crystal 1991 Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD Neurology 41 1402 1409 1653914 1:STN:280:DyaK3Mzmsleiuw%3D%3D 10.1212/WNL.41.9.1402 Dickson DW, Ruan D, Crystal H et al (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology 41:1402–1409
30. 30. K Wakabayashi H Takahashi 1996 Gallyas-positive, tau-negative glial inclusions in Parkinson’s disease midbrain Neurosci Lett 217 133 136 8916090 1:CAS:528:DyaK28XmslGgu7c%3D 10.1016/0304-3940(96)13080-9 Wakabayashi K, Takahashi H (1996) Gallyas-positive, tau-negative glial inclusions in Parkinson’s disease midbrain. Neurosci Lett 217:133–136
31. 31. T Arai K Uéda K Ikeda 1999 Argyrophilic glial inclusions in the midbrain of patients with Parkinson’s disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein Neurosci Lett 259 83 86 10025563 1:CAS:528:DyaK1cXotVKit7k%3D 10.1016/S0304-3940(98)00890-8 Arai T, Uéda K, Ikeda K et al (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson’s disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein. Neurosci Lett 259:83–86
32. 32. K Wakabayashi S Hayashi M Yoshimoto H Kudo H Takahashi 2000 NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains Acta Neuropathol 99 14 20 10651022 1:CAS:528:DyaK1MXnslWru74%3D 10.1007/PL00007400 Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol 99:14–20
33. 33. Y-S Piao K Wakabayashi S Hayashi M Yoshimoto H Takahashi 2000 Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients Clin Neuropathol 19 163 169 10919347 1:STN:280:DC%2BD3M%2FksFeksw%3D%3D Piao Y-S, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H (2000) Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients. Clin Neuropathol 19:163–169
34. 34. N Hishikawa Y Hashizume M Yoshida G Sobue 2001 Widespread occurrence of argyrophilic glial inclusions in Parkinson’s disease Neuropathol Appl Neurobiol 27 362 372 11679088 1:STN:280:DC%2BD3MrntFSgtw%3D%3D 10.1046/j.1365-2990.2001.00345.x Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson’s disease. Neuropathol Appl Neurobiol 27:362–372
35. 35. Y-S Piao F Mori S Hayashi 2003 α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies Acta Neuropathol 105 403 409 12624794 Piao Y-S, Mori F, Hayashi S et al (2003) α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies. Acta Neuropathol 105:403–409
36. 36. R Sengoku Y Saito M Ikemura 2008 Incidence and extent of Lewy body-related α-synucleinopathy in aging human olfactory bulb J Neuropathol Exp Neurol 67 1072 1083 18957894 10.1097/NEN.0b013e31818b4126 Sengoku R, Saito Y, Ikemura M et al (2008) Incidence and extent of Lewy body-related α-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072–1083
37. 37. JW Langston LS Forno 1978 The hypothalamus in Parkinson disease Ann Neurol 3 129 133 350130 1:STN:280:DyaE1c7osFKntw%3D%3D 10.1002/ana.410030207 Langston JW, Forno LS (1978) The hypothalamus in Parkinson disease. Ann Neurol 3:129–133
38. 38. Homma T, Mochizuki Y, Mizutani T (2012) Phosphorylated α-synuclein immunoreactivity in the posterior pituitary lobe. Neuropathology. doi: 10.1111/j.1440-1789.2011.01273.x
39. 39. WA Hartog Jager den J Bethlem 1960 The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans J Neurol Neurosurg Psychiatry 23 283 290 10.1136/jnnp.23.4.283 den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283–290
40. 40. E Ohama F Ikuta 1976 Parkinson’s disease. Distribution of Lewy bodies and monoamine neurons system Acta Neuropathol 34 311 319 179263 1:STN:280:DyaE283gt1ejsA%3D%3D 10.1007/BF00696560 Ohama E, Ikuta F (1976) Parkinson’s disease. Distribution of Lewy bodies and monoamine neurons system. Acta Neuropathol 34:311–319
41. 41. H Braak U Rüb D Sandmann-Keil 2000 Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system Acta Neuropathol 99 489 495 10805091 1:STN:280:DC%2BD3c3mt1ynsw%3D%3D 10.1007/s004010051150 Braak H, Rüb U, Sandmann-Keil D et al (2000) Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 99:489–495
42. 42. A Kakita H Takahashi Y Homma F Ikuta 1994 Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson’s disease Pathol Int 44 878 880 7866573 1:STN:280:DyaK2M7ntV2hug%3D%3D 10.1111/j.1440-1827.1994.tb01688.x Kakita A, Takahashi H, Homma Y, Ikuta F (1994) Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson’s disease. Pathol Int 44:878–880
43. 43. F Mori Y-S Piao S Hayashi 2003 α-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy J Neuropathol Exp Neurol 62 812 819 14503637 1:CAS:528:DC%2BD3sXns1Cjtbc%3D Mori F, Piao Y-S, Hayashi S et al (2003) α-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol 62:812–819
44. 44. K Oyanagi K Wakabayashi E Ohama 1990 Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson’s disease Acta Neuropathol 80 558 559 2251914 1:STN:280:DyaK3M%2FmvVGksw%3D%3D 10.1007/BF00294619 Oyanagi K, Wakabayashi K, Ohama E et al (1990) Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson’s disease. Acta Neuropathol 80:558–559
45. 45. K Wakabayashi H Takahashi 1997 The intermediolateral nucleus and Clarke’s column in Parkinson’s disease Acta Neuropathol 94 287 289 9292699 1:STN:280:DyaK2svjs1OhtA%3D%3D 10.1007/s004010050705 Wakabayashi K, Takahashi H (1997) The intermediolateral nucleus and Clarke’s column in Parkinson’s disease. Acta Neuropathol 94:287–289
46. 46. H Braak M Sastre JR Bohl RA Vos de K Tredici Del 2007 Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre-and postganglionic neurons Acta Neuropathol 113 421 429 17294202 10.1007/s00401-007-0193-x Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre-and postganglionic neurons. Acta Neuropathol 113:421–429
47. 47. T Tamura M Yoshida Y Hashizume G Sobue 2012 Lewy body-related α-synucleinopathy in the spinal cord of cases with incidental Lewy body disease Neuropathology 32 13 22 22243359 10.1111/j.1440-1789.2011.01211.x Tamura T, Yoshida M, Hashizume Y, Sobue G (2012) Lewy body-related α-synucleinopathy in the spinal cord of cases with incidental Lewy body disease. Neuropathology 32:13–22
48. 48. H Braak E Braak D Yilmazer 1994 Amygdala pathology in Parkinson’s disease Acta Neuropathol 88 493 500 7879596 1:STN:280:DyaK2M7osFaqsQ%3D%3D 10.1007/BF00296485 Braak H, Braak E, Yilmazer D et al (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol 88:493–500
49. 49. K Wakabayashi LA Hansen E Masliah 1995 Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32 Acta Neuropathol 89 404 408 7618438 1:STN:280:DyaK2MzktlOiug%3D%3D 10.1007/BF00307643 Wakabayashi K, Hansen LA, Masliah E (1995) Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. Acta Neuropathol 89:404–408
50. 50. LS Forno RL Norville 1976 Ultrastructure of Lewy bodies in the stellate ganglion Acta Neuropathol 34 183 197 178142 1:STN:280:DyaE287otFWjtg%3D%3D 10.1007/BF00688674 Forno LS, Norville RL (1976) Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol 34:183–197
51. 51. K Wakabayashi H Takahashi S Takeda E Ohama F Ikuta 1988 Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses Acta Neuropathol 76 217 221 2850698 1:STN:280:DyaL1M7gt1eqsA%3D%3D 10.1007/BF00687767 Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221
52. 52. H Braak RAI Vos de J Bohl K Tredici Del 2006 Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology Neurosci Lett 396 67 72 16330147 1:CAS:528:DC%2BD28XhsF2gurc%3D 10.1016/j.neulet.2005.11.012 Braak H, de Vos RAI, Bohl J, Del Tredici K (2006) Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72
53. 53. T Lebouvier M Neunlist SB des Varannes 2010 Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms PLoS ONE 5 e12728 20856865 10.1371/journal.pone.0012728 1:CAS:528:DC%2BC3cXhtF2rs73I Lebouvier T, Neunlist M, des Varannes SB et al (2010) Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PLoS ONE 5:e12728
54. 54. TG Beach CH Adler LI Sue 2010 Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders Acta Neuropathol 119 689 702 20306269 1:CAS:528:DC%2BC3cXlslWgtL0%3D 10.1007/s00401-010-0664-3 Beach TG, Adler CH, Sue LI et al (2010) Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702
55. 55. K Iwanaga K Wakabayashi M Yoshimoto 1999 Lewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases Neurology 52 1269 1271 10214756 1:STN:280:DyaK1M3ivFGluw%3D%3D 10.1212/WNL.52.6.1269 Iwanaga K, Wakabayashi K, Yoshimoto M et al (1999) Lewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases. Neurology 52:1269–1271
56. 56. S Orimo T Uchihara A Nakamura 2008 Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease Brain 131 642 650 18079166 10.1093/brain/awm302 Orimo S, Uchihara T, Nakamura A et al (2008) Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain 131:642–650
57. 57. K Wakabayashi H Takahashi 1997 Neuropathology of autonomic nervous system in Parkinson’s disease Eur Neurol 38 Suppl 2 2 7 9387796 10.1159/000113469 Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson’s disease. Eur Neurol 38(Suppl 2):2–7
58. 58. A Minguez-Castellanos CE Chamorro F Escamilla-Sevilla 2007 Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? Neurology 68 2012 2018 17548551 1:CAS:528:DC%2BD2sXlvVaqsbg%3D 10.1212/01.wnl.0000264429.59379.d9 Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F et al (2007) Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? Neurology 68:2012–2018
59. 59. Y Fumimura M Ikemura Y Saito 2007 Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease J Neuropathol Exp Neurol 66 354 362 17483692 10.1097/nen.0b013e3180517454 Fumimura Y, Ikemura M, Saito Y et al (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354–362
60. 60. K Tredici Del CH Hawkes E Ghebremedhin H Braak 2010 Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease Acta Neuropathol 119 703 707 20229352 10.1007/s00401-010-0665-2 Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathol 119:703–707
61. 61. M Ikemura Y Saito R Sengoku 2008 Lewy body pathology involves cutaneous nerves J Neuropathol Exp Neurol 67 945 953 18800013 10.1097/NEN.0b013e318186de48 Ikemura M, Saito Y, Sengoku R et al (2008) Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67:945–953
62. 62. Y Miki M Tomiyama T Ueno 2010 Clinical availability of skin biopsy in the diagnosis of Parkinson’s disease Neurosci Lett 469 357 359 20026177 1:CAS:528:DC%2BC3cXotFSjug%3D%3D 10.1016/j.neulet.2009.12.027 Miki Y, Tomiyama M, Ueno T et al (2010) Clinical availability of skin biopsy in the diagnosis of Parkinson’s disease. Neurosci Lett 469:357–359
63. 63. K Wakabayashi F Mori K Tanji S Orimo H Takahashi 2010 Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain Acta Neuropathol 120 1 12 20532896 10.1007/s00401-010-0706-x Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120:1–12
64. 64. JW Langston 2006 The Parkinson’s complex: Parkinsonism is just the tip of the iceberg Ann Neurol 59 591 596 16566021 10.1002/ana.20834 Langston JW (2006) The Parkinson’s complex: Parkinsonism is just the tip of the iceberg. Ann Neurol 59:591–596
65. 65. SY Lim SH Fox AE Lang 2009 Overview of the extranigral aspects of Parkinson disease Arch Neurol 66 167 172 19204152 10.1001/archneurol.2008.561 Lim SY, Fox SH, Lang AE (2009) Overview of the extranigral aspects of Parkinson disease. Arch Neurol 66:167–172
66. 66. GW Ross RD Abbott H Petrovitch 2006 Association of olfactory dysfunction with incidental Lewy bodies Mov Disord 21 2062 2067 16991138 10.1002/mds.21076 Ross GW, Abbott RD, Petrovitch H et al (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21:2062–2067
67. 67. RD Abbott GW Ross H Petrovitch 2007 Bowel movement frequency in late-life and incidental Lewy bodies Mov Disord 22 1581 1586 17523195 10.1002/mds.21560 Abbott RD, Ross GW, Petrovitch H et al (2007) Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 22:1581–1586
68. 68. TG Beach CH Adler LI Sue 2008 Reduced striatal tyrosine hydroxylase in incidental Lewy body disease Acta Neuropathol 115 445 451 17985144 1:CAS:528:DC%2BD1cXjsFGis7k%3D 10.1007/s00401-007-0313-7 Beach TG, Adler CH, Sue LI et al (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 115:445–451
69. 69. A DelleDonne J Klos H Fujishiro 2008 Incidental Lewy body disease and preclinical Parkinson’s disease Arch Neurol 65 1074 1080 18695057 10.1001/archneur.65.8.1074 DelleDonne A, Klos J, Fujishiro H et al (2008) Incidental Lewy body disease and preclinical Parkinson’s disease. Arch Neurol 65:1074–1080
70. 70. DW Dickson H Fujishiro A DelleDonne 2008 Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease Acta Neuropathol 115 437 444 18264713 10.1007/s00401-008-0345-7 Dickson DW, Fujishiro H, DelleDonne A et al (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease. Acta Neuropathol 115:437–444
71. 71. JN Caviness CH Adler JG Hentz 2011 Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders Clin Neurophysiol 122 2426 2432 21616709 10.1016/j.clinph.2011.03.033 Caviness JN, Adler CH, Hentz JG et al (2011) Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders. Clin Neurophysiol 122:2426–2432
72. 72. H Braak K Tredici Del U Rüb 2003 Staging of brain pathology related to sporadic Parkinson’s disease Neurobiol Aging 24 197 211 12498954 10.1016/S0197-4580(02)00065-9 Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
73. 73. H Braak JR Bohl CM Müller 2006 The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered Mov Disord 21 2042 2051 17078043 10.1002/mds.21065 Braak H, Bohl JR, Müller CM et al (2006) The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21:2042–2051
74. 74. IG McKeith DW Dickson J Lowe 2005 Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 1863 1872 16237129 1:STN:280:DC%2BD2Mnpt1GqsQ%3D%3D 10.1212/01.wnl.0000187889.17253.b1 McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872
75. 75. F Mori K Tanji H Zhang A Kakita H Takahashi K Wakabayashi 2008 α-Synuclein pathology in the neostriatum in Parkinson’s disease Acta Neuropathol 115 453 459 18000672 1:CAS:528:DC%2BD1cXjsFGis7c%3D 10.1007/s00401-007-0316-4 Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K (2008) α-Synuclein pathology in the neostriatum in Parkinson’s disease. Acta Neuropathol 115:453–459
76. 76. H Braak CM Müller U Rüb 2006 Pathology associated with sporadic Parkinson’s disease-where does it end? J Neural Transm Suppl 70 89 97 17017514 10.1007/978-3-211-45295-0_15 Braak H, Müller CM, Rüb U et al (2006) Pathology associated with sporadic Parkinson’s disease-where does it end? J Neural Transm Suppl 70:89–97
77. 77. J Attems KA Jellinger 2008 The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease Neuropathol Appl Neurobiol 34 466 467 18282157 1:STN:280:DC%2BD1cvns1Srsg%3D%3D 10.1111/j.1365-2990.2008.00937.x Attems J, Jellinger KA (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease. Neuropathol Appl Neurobiol 34:466–467
78. 78. L Parkkinen T Pirttila I Alafuzoff 2008 Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance Acta Neuropathol 115 399 407 18297293 10.1007/s00401-008-0346-6 Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399–407
79. 79. DW Dickson H Uchikado H Fujishiro 2010 Evidence in favor of Braak staging of Parkinson’s disease Mov Disord 25 Suppl. 1 S78 S82 20187227 10.1002/mds.22637 Dickson DW, Uchikado H, Fujishiro H et al (2010) Evidence in favor of Braak staging of Parkinson’s disease. Mov Disord 25(suppl 1):S78–S82
80. 80. K Fujimi K Sasaki K Noda 2008 Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study Brain Pathol 18 317 325 18462473 10.1111/j.1750-3639.2008.00169.x Fujimi K, Sasaki K, Noda K et al (2008) Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol 18:317–325
81. 81. KA Jellinger 2008 A critical reappraisal of current staging of Lewy-related pathology in human brain Acta Neuropathol 116 1 16 18592254 1:CAS:528:DC%2BD1cXosVOjtbw%3D 10.1007/s00401-008-0406-y Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1–16
82. 82. ME Kalaitzakis MB Graeber SM Gentleman 2008 The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease: a critical analysis of α-synuclein staging Neuropathol Appl Neurobiol 34 284 295 18053026 1:STN:280:DC%2BD1c3osVejtg%3D%3D 10.1111/j.1365-2990.2007.00923.x Kalaitzakis ME, Graeber MB, Gentleman SM et al (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease: a critical analysis of α-synuclein staging. Neuropathol Appl Neurobiol 34:284–295
83. 83. JB Leverenz R Hamilton DW Tsuang 2008 Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient Brain Pathol 18 220 224 18241240 10.1111/j.1750-3639.2007.00117.x Leverenz JB, Hamilton R, Tsuang DW et al (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220–224
84. 84. J Zaccai C Brayne I McKeith 2008 Patterns and stages of α-synucleinopathy. Relevance in a population-based cohort Neurology 70 1042 1048 18362284 1:CAS:528:DC%2BD1cXjs1Kjtrk%3D 10.1212/01.wnl.0000306697.48738.b6 Zaccai J, Brayne C, McKeith I et al (2008) Patterns and stages of α-synucleinopathy. Relevance in a population-based cohort. Neurology 70:1042–1048
85. 85. TG Beach CH Adler L Lue 2009 Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction Acta Neuropathol 117 613 634 19399512 10.1007/s00401-009-0538-8 Beach TG, Adler CH, Lue L et al (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634
86. 86. TG Beach CL White 3rd CL Hladik 2009 Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders Acta Neuropathol 117 169 174 18982334 1:CAS:528:DC%2BD1MXhtVCltLg%3D 10.1007/s00401-008-0450-7 Beach TG, White CL 3rd, Hladik CL et al (2009) Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174
87. 87. MA Pappolla DL Shank J Alzofon AW Dudley 1988 Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson’s disease Hum Pathol 19 27 31 2447008 1:STN:280:DyaL1c%2FosFWnug%3D%3D 10.1016/S0046-8177(88)80312-5 Pappolla MA, Shank DL, Alzofon J, Dudley AW (1988) Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson’s disease. Hum Pathol 19:27–31
88. 88. WR Gibb T Scott AJ Lees 1991 Neuronal inclusions of Parkinson’s disease Mov Disord 6 2 11 1848677 1:STN:280:DyaK3M7nt1ahuw%3D%3D 10.1002/mds.870060103 Gibb WR, Scott T, Lees AJ (1991) Neuronal inclusions of Parkinson’s disease. Mov Disord 6:2–11
89. 89. GE Dale A Probst P Luthert J Martin BH Anderton PN Leigh 1992 Relationships between Lewy bodies and pale bodies in Parkinson’s disease Acta Neuropathol 83 525 529 1320323 1:STN:280:DyaK38zitV2isA%3D%3D 10.1007/BF00310030 Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationships between Lewy bodies and pale bodies in Parkinson’s disease. Acta Neuropathol 83:525–529
90. 90. H Takahashi K Iwanaga S Egawa F Ikuta 1994 Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-parkinsonian patient Neuropathology 14 73 80 10.1111/j.1440-1789.1994.tb00242.x Takahashi H, Iwanaga K, Egawa S, Ikuta F (1994) Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-parkinsonian patient. Neuropathology 14:73–80
91. 91. K Wakabayashi S Hayashi A Kakita 1998 Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy Acta Neuropathol 96 445 452 9829807 1:CAS:528:DyaK1cXmtFegtb4%3D 10.1007/s004010050918 Wakabayashi K, Hayashi S, Kakita A et al (1998) Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 96:445–452
92. 92. K Wakabayashi F Mori H Takahashi 2006 Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson’s disease Parkinsonism Relat Disord 12 Suppl. 2 S92 98 10.1016/j.parkreldis.2006.05.028 Wakabayashi K, Mori F, Takahashi H (2006) Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson’s disease. Parkinsonism Relat Disord 12(suppl 2):S92–98
93. 93. E Kuusisto L Parkkinen I Alafuzoff 2003 Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62 J Neuropathol Exp Neurol 62 1241 1253 14692700 1:CAS:528:DC%2BD2cXht1Onsw%3D%3D Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241–1253
94. 94. Kovacs GG, Wagner U, Dumont B et al (2012) An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathol
95. 95. O Katsuse E Iseki W Marui K Kosaka 2003 Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies J Neurol Sci 211 29 35 12767494 1:CAS:528:DC%2BD3sXktFWmu78%3D 10.1016/S0022-510X(03)00037-6 Katsuse O, Iseki E, Marui W, Kosaka K (2003) Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 211:29–35
96. 96. T Kanazawa E Adachi S Orimo A Nakamura H Mizusawa T Uchihara 2012 Pale neurites, premature α-synuclein aggregates with centripetal extension from axonal collaterals Brain Pathol 22 67 78 21672073 10.1111/j.1750-3639.2011.00509.x Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature α-synuclein aggregates with centripetal extension from axonal collaterals. Brain Pathol 22:67–78
97. 97. F Mori M Nishie A Kakita M Yoshimoto H Takahashi K Wakabayashi 2006 Relationship among α-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra J Neuropathol Exp Neurol 65 808 815 16896314 1:CAS:528:DC%2BD28XpsFeitbo%3D 10.1097/01.jnen.0000230520.47768.1a Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among α-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808–815
98. 98. K Wakabayashi K Tanji F Mori H Takahashi 2007 The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of α-synuclein aggregates Neuropathology 27 494 506 18018486 10.1111/j.1440-1789.2007.00803.x Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of α-synuclein aggregates. Neuropathology 27:494–506
99. 99. JE Goldman SH Yen FC Chiu NS Peress 1983 Lewy bodies of Parkinson’s disease contain neurofilament antigens Science 221 1082 1084 6308771 1:STN:280:DyaL3s3nsFOksw%3D%3D 10.1126/science.6308771 Goldman JE, Yen SH, Chiu FC, Peress NS (1983) Lewy bodies of Parkinson’s disease contain neurofilament antigens. Science 221:1082–1084
100. 100. ML Schmidt J Murray VM Lee WD Hill A Wertkin JQ Trojanowski 1991 Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies Am J Pathol 139 53 65 1713021 1:STN:280:DyaK3Mzgs12rtQ%3D%3D Schmidt ML, Murray J, Lee VM, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139:53–65
101. 101. IH Liu VN Uversky LA Munishkina AL Fink W Halfter GJ Cole 2005 Agrin binds α-synuclein and modulates α-synuclein fibrillation Glycobiology 15 1320 1331 16037493 1:CAS:528:DC%2BD2MXht1ent7bN 10.1093/glycob/cwj014 Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ (2005) Agrin binds α-synuclein and modulates α-synuclein fibrillation. Glycobiology 15:1320–1331
102. 102. Y Kawamoto I Akiguchi S Nakamura Y Honjyo H Shibasaki H Budka 2002 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains J Neuropathol Exp Neurol 61 245 253 11895039 1:CAS:528:DC%2BD38XisVGrtLc%3D Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 61:245–253
103. 103. A Ubl D Berg C Holzmann 2002 14-3-3 protein is a component of Lewy bodies in Parkinson’s disease—mutation analysis and association studies of 14-3-3 eta Brain Res Mol Brain Res 108 33 39 12480176 1:CAS:528:DC%2BD38XptlWmsbw%3D 10.1016/S0169-328X(02)00510-7 Ubl A, Berg D, Holzmann C et al (2002) 14-3-3 protein is a component of Lewy bodies in Parkinson’s disease—mutation analysis and association studies of 14-3-3 eta. Brain Res Mol Brain Res 108:33–39
104. 104. WP Gai PC Blumbergs WW Blessing 1996 Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson’s disease Acta Neuropathol 91 78 81 8773150 1:CAS:528:DyaK28XhtFyksrw%3D 10.1007/s004010050395 Gai WP, Blumbergs PC, Blessing WW (1996) Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson’s disease. Acta Neuropathol 91:78–81
105. 105. PH Jensen K Islam J Kenney MS Nielsen J Power WP Gai 2000 Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments J Biol Chem 275 21500 21507 10764738 1:CAS:528:DC%2BD3cXkvFGisL0%3D 10.1074/jbc.M000099200 Jensen PH, Islam K, Kenney J, Nielsen MS, Power J, Gai WP (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments. J Biol Chem 275:21500–21507
106. 106. K Wakabayashi S Engelender M Yoshimoto S Tsuji CA Ross H Takahashi 2000 Synphilin-1 is present in Lewy bodies in Parkinson’s disease Ann Neurol 47 521 523 10762166 1:CAS:528:DC%2BD3cXivVyhtLo%3D 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin-1 is present in Lewy bodies in Parkinson’s disease. Ann Neurol 47:521–523
107. 107. K Wakabayashi S Engelender Y Tanaka 2002 Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders Acta Neuropathol 103 209 214 11907799 1:CAS:528:DC%2BD38XhtF2itb4%3D 10.1007/s004010100451 Wakabayashi K, Engelender S, Tanaka Y et al (2002) Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol 103:209–214
108. 108. R Bandopadhyay AE Kingsbury MM Muqit 2005 Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition Neurobiol Dis 20 401 411 15894486 1:CAS:528:DC%2BD2MXhtFCjs7bO 10.1016/j.nbd.2005.03.021 Bandopadhyay R, Kingsbury AE, Muqit MM et al (2005) Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition. Neurobiol Dis 20:401–411
109. 109. PG Galloway C Bergeron G Perry 1989 The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease Neurosci Lett 100 6 10 2548130 1:STN:280:DyaL1MzksVGrsg%3D%3D 10.1016/0304-3940(89)90651-4 Galloway PG, Bergeron C, Perry G (1989) The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease. Neurosci Lett 100:6–10
110. 110. T Ishizawa P Mattila P Davies D Wang DW Dickson 2003 Colocalization of tau and alpha-synuclein epitopes in Lewy bodies J Neuropathol Exp Neurol 62 389 397 12722831 1:CAS:528:DC%2BD3sXjt1yrsbc%3D Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389–397
111. 111. N Hishikawa J Niwa M Doyu 2003 Dorfin localizes to the ubiquitylated inclusions in Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis Am J Pathol 163 609 619 12875980 1:CAS:528:DC%2BD3sXmslSnsLc%3D 10.1016/S0002-9440(10)63688-7 Hishikawa N, Niwa J, Doyu M et al (2003) Dorfin localizes to the ubiquitylated inclusions in Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis. Am J Pathol 163:609–619
112. 112. T Ito J Niwa N Hishikawa S Ishigaki M Doyu G Sobue 2003 Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1 J Biol Chem 278 29106 29114 12750386 1:CAS:528:DC%2BD3sXlsl2msbo%3D 10.1074/jbc.M302763200 Ito T, Niwa J, Hishikawa N, Ishigaki S, Doyu M, Sobue G (2003) Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1. J Biol Chem 278:29106–29114
113. 113. M Nagao H Hayashi 2009 Glycogen synthase kinase-3beta is associated with Parkinson’s disease Neurosci Lett 449 103 107 19007860 1:CAS:528:DC%2BD1cXhsVKrurfE 10.1016/j.neulet.2008.10.104 Nagao M, Hayashi H (2009) Glycogen synthase kinase-3beta is associated with Parkinson’s disease. Neurosci Lett 449:103–107
114. 114. K Tanji T Tanaka F Mori 2006 NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1 Am J Pathol 169 553 565 16877356 1:CAS:528:DC%2BD28XosFaksr4%3D 10.2353/ajpath.2006.051067 Tanji K, Tanaka T, Mori F et al (2006) NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol 169:553–565
115. 115. K Tanji F Mori A Kakita 2007 Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders Acta Neuropathol 114 365 371 17549501 1:CAS:528:DC%2BD2sXhtV2msbrL 10.1007/s00401-007-0238-1 Tanji K, Mori F, Kakita A et al (2007) Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Acta Neuropathol 114:365–371
116. 116. MG Schlossmacher MP Frosch WP Gai 2002 Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies Am J Pathol 160 1655 1667 12000718 1:CAS:528:DC%2BD38XksVKrtLY%3D 10.1016/S0002-9440(10)61113-3 Schlossmacher MG, Frosch MP, Gai WP et al (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160:1655–1667
117. 117. T Murakami M Shoji Y Imai 2004 Pael-R is accumulated in Lewy bodies of Parkinson’s disease Ann Neurol 55 439 442 14991825 1:CAS:528:DC%2BD2cXisFKnur0%3D 10.1002/ana.20064 Murakami T, Shoji M, Imai Y et al (2004) Pael-R is accumulated in Lewy bodies of Parkinson’s disease. Ann Neurol 55:439–442
118. 118. A Ryo T Togo T Nakai 2006 Prolyl-isomerase Pin1 accumulates in Lewy bodies of Parkinson disease and facilitates formation of α-synuclein inclusions J Biol Chem 281 4117 4125 16365047 1:CAS:528:DC%2BD28XhtlKktL0%3D 10.1074/jbc.M507026200 Ryo A, Togo T, Nakai T et al (2006) Prolyl-isomerase Pin1 accumulates in Lewy bodies of Parkinson disease and facilitates formation of α-synuclein inclusions. J Biol Chem 281:4117–4125
119. 119. E Liani A Eyal E Avraham 2004 Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson’s disease Proc Natl Acad Sci U S A 101 5500 5505 15064394 1:CAS:528:DC%2BD2cXjsVagurw%3D 10.1073/pnas.0401081101 Liani E, Eyal A, Avraham E et al (2004) Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson’s disease. Proc Natl Acad Sci U S A 101:5500–5505
120. 120. KS McNaught P Shashidharan DP Perl P Jenner CW Olanow 2002 Aggresome-related biogenesis of Lewy bodies Eur J Neurosci 16 2136 2148 12473081 10.1046/j.1460-9568.2002.02301.x McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW (2002) Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16:2136–2148
121. 121. S Zucchelli M Codrich F Marcuzzi 2010 TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson’s disease brains Hum Mol Genet 19 3759 3770 20634198 1:CAS:528:DC%2BC3cXhtFCrsr3J 10.1093/hmg/ddq290 Zucchelli S, Codrich M, Marcuzzi F et al (2010) TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson’s disease brains. Hum Mol Genet 19:3759–3770
122. 122. K Tanji T Kamitani F Mori A Kakita H Takahashi K Wakabayashi 2010 TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson’s disease and dementia with Lewy bodies Neurobiol Dis 38 210 218 20085810 1:CAS:528:DC%2BC3cXksFCmt7k%3D 10.1016/j.nbd.2010.01.007 Tanji K, Kamitani T, Mori F, Kakita A, Takahashi H, Wakabayashi K (2010) TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson’s disease and dementia with Lewy bodies. Neurobiol Dis 38:210–218
123. 123. J Fergusson M Landon J Lowe 1996 Pathological lesions of Alzheimer’s disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26 S proteasome Neurosci Lett 219 167 170 8971806 1:CAS:528:DyaK28XntlOltLY%3D 10.1016/S0304-3940(96)13192-X Fergusson J, Landon M, Lowe J et al (1996) Pathological lesions of Alzheimer’s disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26 S proteasome. Neurosci Lett 219:167–170
124. 124. K Ii H Ito K Tanaka A Hirano 1997 Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly J Neuropathol Exp Neurol 56 125 131 9034365 1:STN:280:DyaK2s7os1Omsg%3D%3D 10.1097/00005072-199702000-00002 Ii K, Ito H, Tanaka K, Hirano A (1997) Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J Neuropathol Exp Neurol 56:125–131
125. 125. E Lindersson R Beedholm P Hojrup 2004 Proteasomal inhibition by α-synuclein filaments and oligomers J Biol Chem 279 12924 12934 14711827 1:CAS:528:DC%2BD2cXitl2gtbc%3D 10.1074/jbc.M306390200 Lindersson E, Beedholm R, Hojrup P et al (2004) Proteasomal inhibition by α-synuclein filaments and oligomers. J Biol Chem 279:12924–12934
126. 126. K Noda T Kitami WP Gai 2005 Phosphorylated IκBα is a component of Lewy body of Parkinson’s disease Biochem Biophys Res Commun 331 309 317 15845394 1:CAS:528:DC%2BD2MXjsFCht7o%3D 10.1016/j.bbrc.2005.03.167 Noda K, Kitami T, Gai WP et al (2005) Phosphorylated IκBα is a component of Lewy body of Parkinson’s disease. Biochem Biophys Res Commun 331:309–317
127. 127. J Takahashi-Fujigasaki H Fujigasaki 2006 Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies J Neuropathol Appl Neurobiol 32 562 566 1:STN:280:DC%2BD28rkvVOltQ%3D%3D 10.1111/j.1365-2990.2006.00733.x Takahashi-Fujigasaki J, Fujigasaki H (2006) Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies. J Neuropathol Appl Neurobiol 32:562–566
128. 128. S Kwak T Masaki S Ishiura H Sugita 1991 Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains Neurosci Lett 128 21 24 1656333 1:CAS:528:DyaK3MXltFaju70%3D 10.1016/0304-3940(91)90751-E Kwak S, Masaki T, Ishiura S, Sugita H (1991) Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains. Neurosci Lett 128:21–24
129. 129. T Masaki S Ishiura H Sugita S Kwak 1994 Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy J Neurol Sci 122 127 134 8021694 1:CAS:528:DyaK2cXktlansr0%3D 10.1016/0022-510X(94)90288-7 Masaki T, Ishiura S, Sugita H, Kwak S (1994) Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy. J Neurol Sci 122:127–134
130. 130. A Dil Kuazi K Kito Y Abe RW Shin T Kamitani N Ueda 2003 NEDD8 protein is involved in ubiquitinated inclusion bodies J Pathol 199 259 266 12533840 10.1002/path.1283 1:CAS:528:DC%2BD3sXhs1ynsrY%3D Dil Kuazi A, Kito K, Abe Y, Shin RW, Kamitani T, Ueda N (2003) NEDD8 protein is involved in ubiquitinated inclusion bodies. J Pathol 199:259–266
131. 131. F Mori M Nishie YS Piao 2005 Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders Neuropathol Appl Neurobiol 31 53 61 15634231 1:CAS:528:DC%2BD2MXitVamsLo%3D 10.1111/j.1365-2990.2004.00603.x Mori F, Nishie M, Piao YS et al (2005) Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol 31:53–61
132. 132. O Corti C Hampe H Koutnikova 2003 The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration Hum Mol Genet 12 1427 1437 12783850 1:CAS:528:DC%2BD3sXksVWqsbY%3D 10.1093/hmg/ddg159 Corti O, Hampe C, Koutnikova H et al (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 12:1427–1437
133. 133. J Lowe H McDermott M Landon RJ Mayer KD Wilkinson 1990 Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases J Pathol 161 153 160 2166150 1:CAS:528:DyaK3MXktVKgsLg%3D 10.1002/path.1711610210 Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD (1990) Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153–160
134. 134. L Crews B Spencer P Desplats 2010 Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy PLoS One 5 e9313 20174468 10.1371/journal.pone.0009313 1:CAS:528:DC%2BC3cXisVCqsb8%3D Crews L, Spencer B, Desplats P et al (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 5:e9313
135. 135. S Higashi DJ Moore M Minegishi 2011 Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies J Neuropathol Exp Neurol 70 264 280 21412173 1:CAS:528:DC%2BC3MXjslKrt74%3D 10.1097/NEN.0b013e318211c86a Higashi S, Moore DJ, Minegishi M et al (2011) Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies. J Neuropathol Exp Neurol 70:264–280
136. 136. K Tanji F Mori A Kakita H Takahashi K Wakabayashi 2011 Alteration of autophagosomal protein (LC3, GABARAP and GATE-16) in Lewy body disease Neurobiol Dis 43 690 697 21684337 1:CAS:528:DC%2BC3MXptVOjsrc%3D 10.1016/j.nbd.2011.05.022 Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2011) Alteration of autophagosomal protein (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis 43:690–697
137. 137. O Goker-Alpan BK Stubblefield BI Giasson E Sidransky 2010 Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders Acta Neuropathol 120 641 649 20838799 1:CAS:528:DC%2BC3cXhtlSjt77I 10.1007/s00401-010-0741-7 Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E (2010) Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders. Acta Neuropathol 120:641–649
138. 138. Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Acta Neuropathol (in press)
139. 139. Y Kawaguchi JJ Kovacs A McLaurin 2003 The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress Cell 115 727 738 14675537 1:CAS:528:DC%2BD3sXhtVWgurfL 10.1016/S0092-8674(03)00939-5 Kawaguchi Y, Kovacs JJ, McLaurin A et al (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727–738
140. 140. Y Miki F Mori K Tanji A Kakita H Takahashi K Wakabayashi 2011 Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions Neuropathology 31 561 568 21284752 10.1111/j.1440-1789.2011.01200.x Miki Y, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K (2011) Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology 31:561–568
141. 141. Y Shin J Klucken C Patterson BT Hyman PJ McLean 2005 The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal pathways J Biol Chem 280 23727 23734 15845543 1:CAS:528:DC%2BD2MXltlKhsr4%3D 10.1074/jbc.M503326200 Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ (2005) The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem 280:23727–23734
142. 142. K Sasaki K Doh-ura Y Wakisaka T Iwaki 2002 Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with α-synucleinopathies Acta Neuropathol 104 225 230 12172907 1:CAS:528:DC%2BD38XksVaqsro%3D 10.1007/s00401-002-0532-x Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T (2002) Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with α-synucleinopathies. Acta Neuropathol 104:225–230
143. 143. PF Durrenberger MD Filiou LB Moran 2009 DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in parkinsonian astrocytes J Neurosci Res 87 238 245 18711724 1:CAS:528:DC%2BD1MXhtVSrsLY%3D 10.1002/jnr.21819 Durrenberger PF, Filiou MD, Moran LB et al (2009) DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in parkinsonian astrocytes. J Neurosci Res 87:238–245
144. 144. PK Auluck HY Chan JQ Trojanowski VM Lee NM Bonini 2002 Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson’s disease Science 295 865 868 11823645 1:CAS:528:DC%2BD38XhtFemt7w%3D 10.1126/science.1067389 Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295:865–868
145. 145. PJ McLean H Kawamata S Shariff 2002 TorsinA and heat shock proteins act as molecular chaperones: suppression of α-synuclein aggregation J Neurochem 83 846 854 12421356 1:CAS:528:DC%2BD38XovFOisL8%3D 10.1046/j.1471-4159.2002.01190.x McLean PJ, Kawamata H, Shariff S et al (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of α-synuclein aggregation. J Neurochem 83:846–854
146. 146. P Shashidharan PF Good A Hsu DP Perl MF Brin CW Olanow 2000 TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease Brain Res 877 379 381 10986355 1:CAS:528:DC%2BD3cXmtlGrsLc%3D 10.1016/S0006-8993(00)02702-5 Shashidharan P, Good PF, Hsu A, Perl DP, Brin MF, Olanow CW (2000) TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease. Brain Res 877:379–381
147. 147. N Sharma J Hewett LJ Ozelius 2001 A close association of torsinA and α-synuclein in Lewy bodies. A fluorescence resonance energy transfer study Am J Pathol 159 339 344 11438481 1:CAS:528:DC%2BD3MXlslamu7Y%3D 10.1016/S0002-9440(10)61700-2 Sharma N, Hewett J, Ozelius LJ et al (2001) A close association of torsinA and α-synuclein in Lewy bodies. A fluorescence resonance energy transfer study. Am J Pathol 159:339–344
148. 148. T Yamada MA Horisberger N Kawaguchi I Moroo T Toyoda 1994 Immunohistochemistry using antibodies to α-interferon and its induced protein, MxA, in Alzheimer’s and Parkinson’s disease brain tissues Neurosci Lett 181 61 64 7898772 1:CAS:528:DyaK2MXhslOntr8%3D 10.1016/0304-3940(94)90560-6 Yamada T, Horisberger MA, Kawaguchi N, Moroo I, Toyoda T (1994) Immunohistochemistry using antibodies to α-interferon and its induced protein, MxA, in Alzheimer’s and Parkinson’s disease brain tissues. Neurosci Lett 181:61–64
149. 149. R Castellani MA Smith PL Richey G Perry 1996 Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease Brain Res 737 195 200 8930366 1:CAS:528:DyaK28Xms1aqtr0%3D 10.1016/0006-8993(96)00729-9 Castellani R, Smith MA, Richey PL, Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737:195–200
150. 150. G Münch HJ Lüth A Wong 2000 Crosslinking of α-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20 253 257 11207423 10.1016/S0891-0618(00)00096-X Münch G, Lüth HJ, Wong A et al (2000) Crosslinking of α-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20:253–257
151. 151. P Kokoulina TT Rohn 2010 Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson’s disease and dementia with Lewy bodies Neurodegenerative Dis 7 243 250 1:CAS:528:DC%2BC3cXnsVaktL4%3D Kokoulina P, Rohn TT (2010) Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson’s disease and dementia with Lewy bodies. Neurodegenerative Dis 7:243–250
152. 152. R Bandopadhyay AE Kingsbury MR Cookson 2004 The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson’s disease Brain 127 420 430 14662519 10.1093/brain/awh054 Bandopadhyay R, Kingsbury AE, Cookson MR et al (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson’s disease. Brain 127:420–430
153. 153. J Jin GE Meredith L Chen 2005 Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson’s disease Brain Res Mol Brain Res 134 119 138 15790536 1:CAS:528:DC%2BD2MXisFGmurw%3D 10.1016/j.molbrainres.2004.10.003 Jin J, Meredith GE, Chen L et al (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson’s disease. Brain Res Mol Brain Res 134:119–138
154. 154. B Su H Liu X Wang 2009 Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson’s disease Mol Neurodegeneration 4 32 10.1186/1750-1326-4-32 1:CAS:528:DC%2BD1MXptl2qt74%3D Su B, Liu H, Wang X et al (2009) Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson’s disease. Mol Neurodegeneration 4:32
155. 155. JHT Power PC Blumbergs 2009 Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies Acta Neuropathol 117 63 73 18853169 1:CAS:528:DC%2BD1cXhsVeksrfM 10.1007/s00401-008-0438-3 Power JHT, Blumbergs PC (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathol 117:63–73
156. 156. HM Schipper A Liberman EG Stopa 1998 Neural heme oxygenase-1 expression in idiopathic Parkinson’s disease Exp Neurol 150 60 68 9514830 1:STN:280:DyaK1c7ovFWlug%3D%3D 10.1006/exnr.1997.6752 Schipper HM, Liberman A, Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson’s disease. Exp Neurol 150:60–68
157. 157. J Lowe M Landon I Pike I Spendlove H McDermott RJ Mayer 1990 Dementia with β-amyloid deposition: involvement of αB-crystallin supports two main diseases Lancet 336 515 516 1975030 1:STN:280:DyaK3czlsFOisw%3D%3D 10.1016/0140-6736(90)92075-S Lowe J, Landon M, Pike I, Spendlove I, McDermott H, Mayer RJ (1990) Dementia with β-amyloid deposition: involvement of αB-crystallin supports two main diseases. Lancet 336:515–516
158. 158. J Lowe H McDermott I Pike I Spendlove M Landon RJ Mayer 1992 αB crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease J Pathol 166 61 68 1311375 1:STN:280:DyaK387ms12iuw%3D%3D 10.1002/path.1711660110 Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ (1992) αB crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 166:61–68
159. 159. K Nishiyama S Murayama J Shimizu 1995 Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study Acta Neuropathol 89 471 474 7676802 1:STN:280:DyaK2MvgslaksA%3D%3D 10.1007/BF00571500 Nishiyama K, Murayama S, Shimizu J et al (1995) Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study. Acta Neuropathol 89:471–474
160. 160. T Iwatsubo I Nakano K Fukunaga E Miyamoto 1991 Ca 2+ /calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies Acta Neuropathol 82 159 163 1656693 1:STN:280:DyaK38%2FisVyrsw%3D%3D 10.1007/BF00294440 Iwatsubo T, Nakano I, Fukunaga K, Miyamoto E (1991) Ca 2+ /calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies. Acta Neuropathol 82:159–163
161. 161. MY Ryu DW Kim K Arima MM Mouradian SU Kim G Lee 2008 Localization of CKII β subunits in Lewy bodies of Parkinson’s disease J Neurol Sci 266 9 12 17884098 1:CAS:528:DC%2BD1cXhslGhsrk%3D 10.1016/j.jns.2007.08.027 Ryu MY, Kim DW, Arima K, Mouradian MM, Kim SU, Lee G (2008) Localization of CKII β subunits in Lewy bodies of Parkinson’s disease. J Neurol Sci 266:9–12
162. 162. JP Brion AM Couck 1995 Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5 Am J Pathol 147 1465 1476 7485409 1:CAS:528:DyaK28XktVyltw%3D%3D Brion JP, Couck AM (1995) Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am J Pathol 147:1465–1476
163. 163. M Takahashi E Iseki K Kosaka 2000 Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease Brain Res 862 253 256 10799694 1:CAS:528:DC%2BD3cXivVGhu70%3D 10.1016/S0006-8993(00)02086-2 Takahashi M, Iseki E, Kosaka K (2000) Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease. Brain Res 862:253–256
164. 164. I Ferrer R Blanco M Carmona 2001 Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson’s disease and Dementia with Lewy bodies J Neural Transm 108 1383 1396 11810403 1:CAS:528:DC%2BD38Xit1ymtbg%3D 10.1007/s007020100015 Ferrer I, Blanco R, Carmona M et al (2001) Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson’s disease and Dementia with Lewy bodies. J Neural Transm 108:1383–1396
165. 165. S Arawaka M Wada S Goto 2006 The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson’s disease J Neurosci 26 9227 9238 16957079 1:CAS:528:DC%2BD28XpvFWqtbo%3D 10.1523/JNEUROSCI.0341-06.2006 Arawaka S, Wada M, Goto S et al (2006) The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson’s disease. J Neurosci 26:9227–9238
166. 166. E Greggio S Jain A Kingsbury 2006 Kinase activity is required for the toxic effects of mutant LRRK2/dardarin Neurobiol Dis 23 329 341 16750377 1:CAS:528:DC%2BD28Xntl2ntrk%3D 10.1016/j.nbd.2006.04.001 Greggio E, Jain S, Kingsbury A et al (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 23:329–341
167. 167. J Miklossy T Arai JP Guo 2006 LRRK2 expression in normal and pathologic human brain and in human cell lines J Neuropathol Exp Neurol 65 953 963 17021400 1:CAS:528:DC%2BD28XhtFOrsLfI 10.1097/01.jnen.0000235121.98052.54 Miklossy J, Arai T, Guo JP et al (2006) LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol 65:953–963
168. 168. X Zhu SL Siedlak MA Smith G Perry SG Chen 2006 LRRK2 protein is a component of Lewy bodies Ann Neurol 60 617 618 16847950 10.1002/ana.20928 Zhu X, Siedlak SL, Smith MA, Perry G, Chen SG (2006) LRRK2 protein is a component of Lewy bodies. Ann Neurol 60:617–618
169. 169. X Zhu A Babar SL Siedlak 2006 LRRK2 in Parkinson’s disease and dementia with Lewy bodies Mol Neurodegener 1 17 25 17137507 10.1186/1750-1326-1-17 1:CAS:528:DC%2BD28XhtlCmtrfI Zhu X, Babar A, Siedlak SL et al (2006) LRRK2 in Parkinson’s disease and dementia with Lewy bodies. Mol Neurodegener 1:17–25
170. 170. S Gandhi MM Muqit L Stanyer 2006 PINK1 protein in normal human brain and Parkinson’s disease Brain 129 1720 1731 16702191 1:STN:280:DC%2BD28zos1yqug%3D%3D 10.1093/brain/awl114 Gandhi S, Muqit MM, Stanyer L et al (2006) PINK1 protein in normal human brain and Parkinson’s disease. Brain 129:1720–1731
171. 171. T Togo E Iseki W Marui H Akiyama K Uéda K Kosaka 2001 Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies J Neurol Sci 184 71 75 11231035 1:CAS:528:DC%2BD3MXhsFSitLc%3D 10.1016/S0022-510X(00)00498-6 Togo T, Iseki E, Marui W, Akiyama H, Uéda K, Kosaka K (2001) Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. J Neurol Sci 184:71–75
172. 172. S Nakamura Y Kawamoto S Nakano I Akiguchi J Kimura 1997 p35 nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson’s disease Acta Neuropathol 94 153 157 9255390 1:CAS:528:DyaK2sXkslGgtrw%3D 10.1007/s004010050687 Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J (1997) p35 nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson’s disease. Acta Neuropathol 94:153–157
173. 173. S Shimohama G Perry P Richey 1993 Abnormal accumulation of phospholipase C-δ in filamentous inclusions of human neurodegenerative diseases Neurosci Lett 162 183 186 8121625 1:CAS:528:DyaK2cXnsVOjug%3D%3D 10.1016/0304-3940(93)90591-8 Shimohama S, Perry G, Richey P et al (1993) Abnormal accumulation of phospholipase C-δ in filamentous inclusions of human neurodegenerative diseases. Neurosci Lett 162:183–186
174. 174. E Junn RD Ronchetti MM Quezado SY Kim MM Mouradian 2003 Tissue transglutaminase-induced aggregation of α-synuclein: implications for Lewy body formation in Parkinson’s disease and dementia with Lewy bodies Proc Natl Acad Sci U S A 100 2047 2052 12576551 1:CAS:528:DC%2BD3sXhsFGrsbg%3D 10.1073/pnas.0438021100 Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM (2003) Tissue transglutaminase-induced aggregation of α-synuclein: implications for Lewy body formation in Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 100:2047–2052
175. 175. PG Galloway I Grundke-Iqbal K Iqbal G Perry 1988 Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles J Neuropathol Exp Neurol 47 654 663 2459316 1:STN:280:DyaL1M%2FhtVyguw%3D%3D 10.1097/00005072-198811000-00008 Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–663
176. 176. T Fukuda J Tanaka K Watabe RT Numoto M Minamitani 1993 Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease Acta Pathol Jpn 43 545 551 8291442 1:STN:280:DyaK2c7itV2msg%3D%3D Fukuda T, Tanaka J, Watabe K, Numoto RT, Minamitani M (1993) Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease. Acta Pathol Jpn 43:545–551
177. 177. MR D’Andrea S Ilyin CR Plata-Salaman 2001 Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson’s disease substantia nigra brain tissues Neurosci Lett 306 137 140 11406314 10.1016/S0304-3940(01)01811-0 D’Andrea MR, Ilyin S, Plata-Salaman CR (2001) Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson’s disease substantia nigra brain tissues. Neurosci Lett 306:137–140
178. 178. M Ihara H Tomimoto H Kitayama 2003 Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson’s disease and other synucleinopathies J Biol Chem 278 24095 24102 12695511 1:CAS:528:DC%2BD3sXkslyns78%3D 10.1074/jbc.M301352200 Ihara M, Tomimoto H, Kitayama H et al (2003) Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson’s disease and other synucleinopathies. J Biol Chem 278:24095–24102
179. 179. GG Kovács L László J Kovács 2004 Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies Neurobiol Dis 17 155 162 15474353 10.1016/j.nbd.2004.06.006 1:CAS:528:DC%2BD2cXotlSlsb4%3D Kovács GG, László L, Kovács J et al (2004) Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol Dis 17:155–162
180. 180. E Lindersson D Lundvig C Petersen 2005 p25α stimulates α-synuclein aggregation and is co-localized with aggregated α-synuclein in α-synucleinopathies J Biol Chem 280 5703 5715 15590652 1:CAS:528:DC%2BD2MXhtlClsb4%3D 10.1074/jbc.M410409200 Lindersson E, Lundvig D, Petersen C et al (2005) p25α stimulates α-synuclein aggregation and is co-localized with aggregated α-synuclein in α-synucleinopathies. J Biol Chem 280:5703–5715
181. 181. L Bedford D Hay A Devoy 2008 Depletion of 26 S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies J Neurosci 28 8189 8198 18701681 1:CAS:528:DC%2BD1cXhtVaktLjN 10.1523/JNEUROSCI.2218-08.2008 Bedford L, Hay D, Devoy A et al (2008) Depletion of 26 S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 28:8189–8198
182. 182. M Hashimoto A Takeda LJ Hsu T Takenouchi E Masliah 1999 Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease J Biol Chem 274 28849 28852 10506125 1:CAS:528:DyaK1MXmslWqs70%3D 10.1074/jbc.274.41.28849 Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, Masliah E (1999) Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease. J Biol Chem 274:28849–28852
183. 183. KM Strauss LM Martins H Plun-Favreau 2005 Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson’s disease Hum Mol Genet 14 2099 2111 15961413 1:CAS:528:DC%2BD2MXmt1ersL4%3D 10.1093/hmg/ddi215 Strauss KM, Martins LM, Plun-Favreau H et al (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson’s disease. Hum Mol Genet 14:2099–2111
184. 184. Y Kawamoto Y Kobayashi Y Suzuki 2008 Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with α-synucleinopathies J Neuropathol Exp Neurol 67 984 993 18800009 10.1097/NEN.0b013e31818809f4 Kawamoto Y, Kobayashi Y, Suzuki Y et al (2008) Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with α-synucleinopathies. J Neuropathol Exp Neurol 67:984–993
185. 185. SS Lee YM Kim E Junn 2003 Cell cycle aberrations by α-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies Neurobiol Aging 24 687 696 12885576 1:CAS:528:DC%2BD3sXls1Omtbk%3D 10.1016/S0197-4580(02)00196-3 Lee SS, Kim YM, Junn E et al (2003) Cell cycle aberrations by α-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Neurobiol Aging 24:687–696
186. 186. KL Jordan-Sciutto R Dorsey EM Chalovich RR Hammond CL Achim 2003 Expression patterns of retinoblastoma protein in Parkinson disease J Neuropathol Exp Neurol 62 68 74 12528819 1:CAS:528:DC%2BD3sXpsVKntg%3D%3D Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL (2003) Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 62:68–74
187. 187. H Arai VM Lee WD Hill BD Greenberg JQ Trojanowski 1992 Lewy bodies contain beta-amyloid precursor proteins of Alzheimer’s disease Brain Res 585 386 390 1511324 1:CAS:528:DyaK38XlsVymsrw%3D 10.1016/0006-8993(92)91242-7 Arai H, Lee VM, Hill WD, Greenberg BD, Trojanowski JQ (1992) Lewy bodies contain beta-amyloid precursor proteins of Alzheimer’s disease. Brain Res 585:386–390
188. 188. T Yamada PL McGeer KG Baimbridge EG McGeer 1990 Relative sparing in Parkinson’s disease of substantia nigra dopamine neurons containing calbindin-D 28K Brain Res 526 303 307 2257487 1:CAS:528:DyaK3cXlvV2itL4%3D 10.1016/0006-8993(90)91236-A Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson’s disease of substantia nigra dopamine neurons containing calbindin-D 28K. Brain Res 526:303–307
189. 189. BN Dugger DW Dickson 2010 Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies Acta Neuropathol 120 633 639 20721565 1:CAS:528:DC%2BC3cXhtlSjt77N 10.1007/s00401-010-0739-1 Dugger BN, Dickson DW (2010) Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol 120:633–639
190. 190. M Nishimura H Tomimoto T Suenaga 1994 Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson’s disease brains Brain Res 634 339 344 8131084 1:STN:280:DyaK2c7nslGjsg%3D%3D 10.1016/0006-8993(94)91940-2 Nishimura M, Tomimoto H, Suenaga T et al (1994) Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson’s disease brains. Brain Res 634:339–344
191. 191. DP Huynh DR Scoles D Nguyen SM Pulst 2003 The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI Hum Mol Genet 12 2587 2597 12925569 1:CAS:528:DC%2BD3sXot1Cqtr4%3D 10.1093/hmg/ddg269 Huynh DP, Scoles DR, Nguyen D, Pulst SM (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet 12:2587–2597
192. 192. S Nakashima F Ikuta 1984 Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains J Neurol Sci 66 91 96 6151589 1:CAS:528:DyaL2MXktlyrsg%3D%3D 10.1016/0022-510X(84)90144-8 Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96
193. 193. S Yamamoto J Fukae H Mori Y Mizuno N Hattori 2006 Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra Neurosci Lett 396 187 191 16386370 1:CAS:528:DC%2BD28XitVCqsLc%3D 10.1016/j.neulet.2005.11.068 Yamamoto S, Fukae J, Mori H, Mizuno Y, Hattori N (2006) Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra. Neurosci Lett 396:187–191
194. 194. Pappolla MA, Andorn AC, Chou SM (1985) Serum protein antigens within Lewy bodies in Parkinson’s disease. Ann Neurol 18: 136 (abstract)
195. 195. G Perry P Richey SL Siedlak P Galloway M Kawai P Cras 1992 Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases Brain Res 579 350 352 1628222 1:CAS:528:DyaK38XksVGqsr4%3D 10.1016/0006-8993(92)90074-J Perry G, Richey P, Siedlak SL, Galloway P, Kawai M, Cras P (1992) Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases. Brain Res 579:350–352
196. 196. DA DeWitt PL Richey D Praprotnik J Silver G Perry 1994 Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases Brain Res 656 205 209 7804839 1:CAS:528:DyaK2cXlslKksbc%3D 10.1016/0006-8993(94)91386-2 DeWitt DA, Richey PL, Praprotnik D, Silver J, Perry G (1994) Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res 656:205–209
197. 197. T Yamada PL McGeer EG McGeer 1992 Lewy bodies in Parkinson’s disease are recognized by antibodies to complement proteins Acta Neuropathol 84 100 104 1502878 1:STN:280:DyaK38zmslCisQ%3D%3D 10.1007/BF00427222 Yamada T, McGeer PL, McGeer EG (1992) Lewy bodies in Parkinson’s disease are recognized by antibodies to complement proteins. Acta Neuropathol 84:100–104
198. 198. DA Loeffler DM Camp SB Conant 2006 Complement activation in the Parkinson’s disease substantia nigra: an immunocytochemical study J Neuroinflammation 3 29 36 17052351 10.1186/1742-2094-3-29 1:CAS:528:DC%2BD28XhtFOitrbL Loeffler DA, Camp DM, Conant SB (2006) Complement activation in the Parkinson’s disease substantia nigra: an immunocytochemical study. J Neuroinflammation 3:29–36
199. 199. T Wisniewski M Haltia J Ghiso B Frangione 1991 Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type Am J Pathol 138 1077 1083 1850958 1:STN:280:DyaK3M3itFWkug%3D%3D Wisniewski T, Haltia M, Ghiso J, Frangione B (1991) Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type. Am J Pathol 138:1077–1083
200. 200. J Oláh N Tokési O Vincze 2006 Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies FEBS Lett 580 5807 5814 17027006 10.1016/j.febslet.2006.09.037 1:CAS:528:DC%2BD28XhtFWiu7nM Oláh J, Tokési N, Vincze O et al (2006) Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies. FEBS Lett 580:5807–5814
201. 201. CF Orr DB Rowe Y Mizuno H Mori GM Halliday 2005 A possible role for humoral immunity in the pathogenesis of Parkinson’s disease Brain 128 2665 2674 16219675 10.1093/brain/awh625 Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM (2005) A possible role for humoral immunity in the pathogenesis of Parkinson’s disease. Brain 128:2665–2674
202. 202. WA Hartog Jager den 1969 Sphingomyelin in Lewy inclusion bodies in Parkinson’s disease Arch Neurol 21 615 619 10.1001/archneur.1969.00480180071006 den Hartog Jager WA (1969) Sphingomyelin in Lewy inclusion bodies in Parkinson’s disease. Arch Neurol 21:615–619
203. 203. MR Issidorides MT Panayotacopoulou G Tiniacos 1990 Similarities between neuronal Lewy bodies in parkinsonism and hepatic Mallory bodies in alcoholism Pathol Res Pract 186 473 478 2247376 1:STN:280:DyaK3M%2Fmt1ajug%3D%3D 10.1016/S0344-0338(11)80466-8 Issidorides MR, Panayotacopoulou MT, Tiniacos G (1990) Similarities between neuronal Lewy bodies in parkinsonism and hepatic Mallory bodies in alcoholism. Pathol Res Pract 186:473–478
204. 204. WP Gai HX Yuan XQ Li JT Power PC Blumbergs PH Jensen 2000 In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies Exp Neurol 166 324 333 11085897 1:CAS:528:DC%2BD3cXotFCrsbo%3D 10.1006/exnr.2000.7527 Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, Jensen PH (2000) In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166:324–333
205. 205. PG Galloway G Perry 1991 Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology Brain Res 541 347 349 2054646 1:CAS:528:DyaK3MXhs1Wqsbw%3D 10.1016/0006-8993(91)91036-Z Galloway PG, Perry G (1991) Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology. Brain Res 541:347–349
206. 206. JB Leverenz I Umar Q Wang 2007 Proteomic identification of novel proteins in cortical Lewy bodies Brain Pathol 17 139 145 17388944 1:CAS:528:DC%2BD2sXls12rsrY%3D 10.1111/j.1750-3639.2007.00048.x Leverenz JB, Umar I, Wang Q et al (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139–145
207. 207. PJ Whitehouse JC Hedreen CL White 3rd DL Price 1983 Basal forebrain neurons in the dementia of Parkinson disease Ann Neurol 13 243 248 6847136 1:STN:280:DyaL3s3gt1Oguw%3D%3D 10.1002/ana.410130304 Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13:243–248
208. 208. K Wakabayashi A Kakita S Hayashi 1998 Apolipoprotein E ε4 allele and progression of cortical Lewy body pathology in Parkinson’s disease Acta Neuropathol 95 450 454 9600590 1:CAS:528:DyaK1cXitVygtrc%3D 10.1007/s004010050824 Wakabayashi K, Kakita A, Hayashi S et al (1998) Apolipoprotein E ε4 allele and progression of cortical Lewy body pathology in Parkinson’s disease. Acta Neuropathol 95:450–454
209. 209. PM Mattila M Röyttä H Torikka DW Dickson JO Rinne 1998 Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease Acta Neuropathol 95 576 582 9650749 1:STN:280:DyaK1czht1Oluw%3D%3D 10.1007/s004010050843 Mattila PM, Röyttä M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease. Acta Neuropathol 95:576–582
210. 210. E Kövari G Gold FR Herrmann 2003 Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease Acta Neuropathol 106 83 88 12687392 Kövari E, Gold G, Herrmann FR et al (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease. Acta Neuropathol 106:83–88
211. 211. Terry RD (2000) Do neuronal inclusions kill the cell? J Neural Transm 59 (Suppl.): 91-93
212. 212. HA Lashuel BM Petre J Wall 2002 α-Synuclein, especially the Parkinson’s disease-associated mutants, forms pore-like annular and tubular protofibrils J Mol Biol 322 1089 1102 12367530 1:CAS:528:DC%2BD38XnsVant7c%3D 10.1016/S0022-2836(02)00735-0 Lashuel HA, Petre BM, Wall J et al (2002) α-Synuclein, especially the Parkinson’s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089–1102
213. 213. TT Ding SJ Lee JC Rochet PT Lansbury Jr 2002 Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes Biochemistry 41 10209 10217 12162735 1:CAS:528:DC%2BD38XlsVShurc%3D 10.1021/bi020139h Ding TT, Lee SJ, Rochet JC, Lansbury PT Jr (2002) Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41:10209–10217
214. 214. HA Lashuel D Hartley BM Petre T Walz PT Lansbury Jr 2002 Amyloid pores from pathogenic mutations Nature 418 291 12124613 1:CAS:528:DC%2BD38XltlGmsrc%3D 10.1038/418291a Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr (2002) Amyloid pores from pathogenic mutations. Nature 418:291
215. 215. L Chen MB Feany 2005 α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease Nat Neurosci 8 657 663 15834418 1:CAS:528:DC%2BD2MXjsFyktL0%3D 10.1038/nn1443 Chen L, Feany MB (2005) α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8:657–663
216. 216. H Sawada R Kohno T Kihara 2004 Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes α-synuclein inclusions J Biol Chem 279 10710 10719 14672949 1:CAS:528:DC%2BD2cXhvFChtrw%3D 10.1074/jbc.M308434200 Sawada H, Kohno R, Kihara T et al (2004) Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes α-synuclein inclusions. J Biol Chem 279:10710–10719
217. 217. CW Olanow DP Perl GN DeMartino KS McNaught 2004 Lewy-body formation is an aggresome-related process: a hypothesis Lancet Neurol 3 496 503 15261611 10.1016/S1474-4422(04)00827-0 Olanow CW, Perl DP, DeMartino GN, McNaught KS (2004) Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 3:496–503
218. 218. M Tanaka YM Kim G Lee 2004 Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective J Biol Chem 279 4625 4631 14627698 1:CAS:528:DC%2BD2cXps12ksw%3D%3D 10.1074/jbc.M310994200 Tanaka M, Kim YM, Lee G et al (2004) Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279:4625–4631
219. 219. T Pan S Kondo W Le J Jankovic 2008 The role of autophagy–lysosome pathway in neurodegeneration associated with Parkinson’s disease Brain 131 1969 1978 18187492 10.1093/brain/awm318 Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy–lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain 131:1969–1978
220. 220. UB Pandey Z Nie Y Batlevi 2007 HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS Nature 447 859 863 17568747 1:CAS:528:DC%2BD2sXms1WjsL8%3D 10.1038/nature05853 Pandey UB, Nie Z, Batlevi Y et al (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447:859–863
221. 221. T Johansen T Lamark 2011 Selective autophagy mediated by autophagic adapter proteins Autophagy 7 279 296 21189453 1:CAS:528:DC%2BC3MXjvFOhsr0%3D 10.4161/auto.7.3.14487 Johansen T, Lamark T (2011) Selective autophagy mediated by autophagic adapter proteins. Autophagy 7:279–296
222. 222. A Sidhu C Wersinger P Vernier 2004 Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 18 637 647 15054086 1:CAS:528:DC%2BD2cXjtFWitLo%3D 10.1096/fj.03-1112rev Sidhu A, Wersinger C, Vernier P (2004) Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 18:637–647
223. 223. A Takeda M Mallory M Sundsmo W Honer L Hansen E Masliah 1998 Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders Am J Pathol 152 367 372 9466562 1:STN:280:DyaK1c7is1Sgug%3D%3D Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E (1998) Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 152:367–372
224. 224. A Takeda M Hashimoto M Mallory M Sundsumo L Hansen E Masliah 2000 C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders Acta Neuropathol 99 296 304 10663973 1:CAS:528:DC%2BD3cXms1Cqug%3D%3D 10.1007/PL00007441 Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Masliah E (2000) C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol 99:296–304
225. 225. K Tanji F Mori J Mimura 2010 Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice Acta Neuropathol 120 145 154 20339856 1:CAS:528:DC%2BC3cXotVKnsbs%3D 10.1007/s00401-010-0676-z Tanji K, Mori F, Mimura J et al (2010) Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice. Acta Neuropathol 120:145–154
226. 226. K Tanji F Mori A Kakita H Takahashi K Wakabayashi 2011 Synphilin-1 binding protein, NUB1, is colocalized with non-fibrillar, proteinase K-resistant α-synuclein to presynapses in Lewy body disease J Neuropathol Exp Neurol 70 879 889 21937912 1:CAS:528:DC%2BC3MXht1SltLrN 10.1097/NEN.0b013e3182303745 Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2011) Synphilin-1 binding protein, NUB1, is colocalized with non-fibrillar, proteinase K-resistant α-synuclein to presynapses in Lewy body disease. J Neuropathol Exp Neurol 70:879–889